NO20010044D0 - Anvendelse av texapyriner i makrofag-medierte sykdommer - Google Patents
Anvendelse av texapyriner i makrofag-medierte sykdommerInfo
- Publication number
- NO20010044D0 NO20010044D0 NO20010044A NO20010044A NO20010044D0 NO 20010044 D0 NO20010044 D0 NO 20010044D0 NO 20010044 A NO20010044 A NO 20010044A NO 20010044 A NO20010044 A NO 20010044A NO 20010044 D0 NO20010044 D0 NO 20010044D0
- Authority
- NO
- Norway
- Prior art keywords
- macrophage
- texapyrins
- mediated diseases
- texaphyrins
- subject
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11050998A | 1998-07-06 | 1998-07-06 | |
| PCT/US1999/015199 WO2000001414A1 (en) | 1998-07-06 | 1999-07-06 | Use of texaphyrins in macrophage-mediated disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20010044D0 true NO20010044D0 (no) | 2001-01-04 |
| NO20010044L NO20010044L (no) | 2001-03-01 |
Family
ID=22333401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20010044A NO20010044L (no) | 1998-07-06 | 2001-01-04 | Anvendelse av texafyriner i makrofag-medierte sykdommer |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1094840A1 (no) |
| JP (1) | JP2002519390A (no) |
| KR (1) | KR20010079498A (no) |
| AR (1) | AR019226A1 (no) |
| AU (1) | AU4860899A (no) |
| CA (1) | CA2336134A1 (no) |
| NO (1) | NO20010044L (no) |
| WO (1) | WO2000001414A1 (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6163988A (en) * | 1995-05-17 | 2000-12-26 | Rockland, Inc. | Assembly connectable to an operating arm of a machine for performing work functions |
| RU2106146C1 (ru) | 1995-07-17 | 1998-03-10 | Институт элементоорганических соединений РАН | Средство для подавления опухолевого роста |
| EP1227844A2 (en) | 1999-10-29 | 2002-08-07 | Pharmacyclics, Inc. | Compositions for treating atheroma and neoplastic tissue |
| US7579338B2 (en) | 1999-10-29 | 2009-08-25 | Pharmacyclics, Inc. | Methods and compositions for treating atheroma, tumors and other neoplastic tissues |
| JP2003012547A (ja) * | 2001-06-27 | 2003-01-15 | Meiji Seika Kaisha Ltd | インスリン依存性糖尿病の診断剤および治療剤 |
| CN103405769A (zh) * | 2013-03-07 | 2013-11-27 | 北京亿仁赛博医疗科技研发中心有限公司 | 光敏剂在制备治疗疾病的病毒灭活药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5457183A (en) * | 1989-03-06 | 1995-10-10 | Board Of Regents, The University Of Texas System | Hydroxylated texaphyrins |
| US5419760A (en) * | 1993-01-08 | 1995-05-30 | Pdt Systems, Inc. | Medicament dispensing stent for prevention of restenosis of a blood vessel |
| US6008211A (en) * | 1995-07-27 | 1999-12-28 | Pdt Pharmaceuticals, Inc. | Photoactivatable compounds comprising benzochlorin and furocoumarin |
| US5913884A (en) * | 1996-09-19 | 1999-06-22 | The General Hospital Corporation | Inhibition of fibrosis by photodynamic therapy |
-
1999
- 1999-07-05 AR ARP990103250A patent/AR019226A1/es unknown
- 1999-07-06 KR KR1020017000150A patent/KR20010079498A/ko not_active Withdrawn
- 1999-07-06 CA CA002336134A patent/CA2336134A1/en not_active Abandoned
- 1999-07-06 AU AU48608/99A patent/AU4860899A/en not_active Abandoned
- 1999-07-06 WO PCT/US1999/015199 patent/WO2000001414A1/en not_active Ceased
- 1999-07-06 JP JP2000557860A patent/JP2002519390A/ja active Pending
- 1999-07-06 EP EP99932263A patent/EP1094840A1/en not_active Withdrawn
-
2001
- 2001-01-04 NO NO20010044A patent/NO20010044L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2336134A1 (en) | 2000-01-13 |
| EP1094840A1 (en) | 2001-05-02 |
| WO2000001414A1 (en) | 2000-01-13 |
| NO20010044L (no) | 2001-03-01 |
| KR20010079498A (ko) | 2001-08-22 |
| AR019226A1 (es) | 2001-12-26 |
| JP2002519390A (ja) | 2002-07-02 |
| AU4860899A (en) | 2000-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO993393D0 (no) | Fotokjemoterapeutiske blandinger | |
| NO20050807L (no) | Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser | |
| DE60026538D1 (de) | Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen | |
| IS4972A (is) | Notkun klóbindiefnisins klíókínól við að framleiða lyfjablöndu til að meðhöndla Alzheimers-sjúkdóm | |
| DK1296652T3 (da) | Topiske farmaceutiske formuleringer og behandlingsfremgangsmåder | |
| YU37602A (sh) | Derivat pirolidinacetamida sam ili u kombinaciji za tretman poremećaja cns | |
| CY1106602T1 (el) | Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων | |
| DE60037394D1 (de) | VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE | |
| CY1108629T1 (el) | Συνδυασμος ετ 743 με 5 φθοριοουρακιλο προ-φαρμακα δια την θεραπευτικη αγωγη του καρκικου | |
| DE60324427D1 (de) | Verfahren zur modulation der tubulindeacetylase-aktivität | |
| DE69426334D1 (de) | Parenterales Busulfan zur Behandlung von malignen Krankheiten | |
| ID27576A (id) | Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun | |
| NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
| NO20050718L (no) | Topikal behandling av hudsykdommer | |
| NO20010044D0 (no) | Anvendelse av texapyriner i makrofag-medierte sykdommer | |
| ID23528A (id) | Pengobatan terapeutik untuk gangguan kulit | |
| ITRM960364A0 (it) | Agente attivo terapeutico per il trattamento di malattie degenerative neuronali. | |
| PT900563E (pt) | Producao de formulacoes farmaceuticas para o tratamento de edema e doencas venosas | |
| ATE199641T1 (de) | Terpenderivate (sarcodictyine) als antikrebsmittel | |
| SE9902597D0 (sv) | New use | |
| CY1106702T1 (el) | Χρηση ενος συνδυασμου μιας πουρινης και ενος παραγοντα δοτη μονοξειδιου του αζωτου για την προληψη ή την αγωγη γενετησιων δυσλειτουργιων | |
| DE60216292D1 (de) | Calciumtrifluoracetat mit zytotoxischer wirkung | |
| RU94024337A (ru) | Антиметастатическое средство | |
| NO984196D0 (no) | Fremgangsmåte for behandling av stoffmisbruk | |
| DE69635282D1 (de) | Behandlung der exzessiven aggressivität mit olanzapine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |